CARISMA Therapeutics to Participate in Upcoming Investor Conferences
PHILADELPHIA — CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present at two virtual conferences in August 2020.
LifeSci Partners Private Company Virtual Summer Symposium
Tuesday, August 4, 2020 at 3:30 p.m. EDT
Wedbush PacGrow Healthcare Virtual Conference
Wednesday, August 12, 2020 at 12:35 p.m. EDT
About CARISMA Therapeutics Inc.
CARISMA Therapeutics Inc. is a biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. CARISMA Therapeutics is headquartered in Philadelphia, PA.
Media Contact:
Christina Khoury-Folkens
612-806-0757
ckhoury@w2ogroup.com